Compare Charles Schwab Corporation Common Stock (SCHW) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles Schwab Corporation Common Stock vs Twist Bioscience Corp — how do they compare? Charles Schwab Corporation Common Stock trades at $100.1 (market cap $178.33B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 32.7× Twist Bioscience Corp's market cap, and Charles Schwab Corporation Common Stock pays a 1.25% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| SCHW | TWST | |
|---|---|---|
Market Cap | $178.33B | $5.45B |
Sector | Financials | Health |
52-Week High | $107.21 | $102.88 |
52-Week Low | $85.35 | $24.16 |
Dividend Yield | 1.25% | — |
Enterprise Value | — | $5.37B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles Schwab Corporation Common Stock
Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
